111 Capital Trims Stock Position in McKesson Corporation

Institutional investor reduces stake in major healthcare services and distribution company

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

111 Capital, an institutional investor, has reduced its stake in McKesson Corporation (NYSE:MCK) by 76.5% in the third quarter, according to a recent SEC filing. The investor now owns 295 shares of the company's stock, down from 1,257 shares previously.

Why it matters

This move by 111 Capital reflects broader trends in the healthcare industry, as investors closely monitor the performance and positioning of major players like McKesson. The company's stock price and institutional ownership are closely watched by analysts and the broader market.

The details

According to the SEC filing, 111 Capital sold 962 shares of McKesson stock during the third quarter, reducing its total holdings to 295 shares. The investor's remaining stake in McKesson is now valued at $228,000. The filing does not provide specific reasons for the reduced position.

  • 111 Capital filed the SEC report detailing the stock sale in the 3rd quarter of 2026.

The players

111 Capital

An institutional investor that has reduced its stake in McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.

Got photos? Submit your photos here. ›

The takeaway

This reduction in 111 Capital's McKesson holdings reflects the ongoing shifts and scrutiny in the healthcare industry, as investors carefully evaluate the performance and positioning of major players like McKesson. The company's stock price and institutional ownership remain important indicators to watch for industry analysts and the broader market.